Company

SymBio Pharmaceuticals Ltd

Headquarters: Tokyo, Japan

Employees: 127

CEO: Mr. Fuminori Yoshida

JPX: 4582 +1.68%

Market Cap

¥8.06 Billion

JPY as of July 1, 2024

US$49.9 Million

Market Cap History

SymBio Pharmaceuticals Ltd market capitalization over time

Evolution of SymBio Pharmaceuticals Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of SymBio Pharmaceuticals Ltd

Detailed Description

SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology in Japan. It is involved in the development of Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia under the TREAKISYM name; and is in the Phase III clinical trial to treat relapsed/refractory diffuse large B-cell lymphoma. The company also engages in the development of SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid formulation. In addition, it is involved in the development of SyB L-1101, an intravenous formulation, which is in Phase III clinical trial for the treatment of higher-risk myelodysplastic syndromes (HR-MDS); and SyB C-1101, an oral formulation that is in Phase II/III clinical trial in combination with Azacitidine to treat HR-MDS. Further, it engages in the development of SyB V-1901, an antiviral drug for the treatment of infectious diseases. SymBio Pharmaceuticals Limited was incorporated in 2005 and is based in Tokyo, Japan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

SymBio Pharmaceuticals Ltd has the following listings and related stock indices.


Stock: JPX: 4582 wb_incandescent

Details

Headquarters:

Toranomon 30 Mori Building

3-2-2 Toranomon Minato-ku

Tokyo, 105-0001

Japan

Phone: 81 3 5472 1125

Fax: 81 3 5472 3054